Percutaneous tibial nerve stimulation for the overactive bladder: A single-arm trial.
3/5 보강
TL;DR
It is hypothesised that PTNS is a safe and effective treatment for OAB and has emerged as a non‐invasive treatment option for OAB.
🔎 핵심 키워드
보툴리눔독소 주사
bladder
third-line
OAB
beta-adrenoreceptor
Urinary
PTNS
Overactive bladder
전체 NER ↓
연도별 인용 (2024–2026) · 합계 5
OpenAlex 토픽 ·
Urinary Bladder and Prostate Research
Pelvic floor disorders treatments
Prostate Cancer Diagnosis and Treatment
It is hypothesised that PTNS is a safe and effective treatment for OAB and has emerged as a non‐invasive treatment option for OAB.
- p-value P < 0.01
APA
H Kyaw, Hannah Krause, Judith Goh (2024). Percutaneous tibial nerve stimulation for the overactive bladder: A single-arm trial.. The Australian & New Zealand journal of obstetrics & gynaecology, 64(5), 501-505. https://doi.org/10.1111/ajo.13822
MLA
H Kyaw, et al.. "Percutaneous tibial nerve stimulation for the overactive bladder: A single-arm trial.." The Australian & New Zealand journal of obstetrics & gynaecology, vol. 64, no. 5, 2024, pp. 501-505.
PMID
38632883 ↗
Abstract 한글 요약
[AIMS] We hypothesise that PTNS is a safe and effective treatment for OAB. Overactive bladder (OAB) is estimated to affect 11.8% of women worldwide, causing diminished quality of life. Lifestyle modifications, muscarinic receptor antagonist and beta-adrenoreceptor agonist remain the mainstay of treatment but are limited by their efficacy and adverse effects. Access to third-line therapies of intravesical botulinum toxin type A or sacral neuromodulation is limited by their invasive nature. Percutaneous tibial nerve stimulation (PTNS) has emerged as a non-invasive treatment option for OAB.
[METHODS] This study was a single-arm trial of women requesting third-line treatment for OAB. The primary treatment outcome was patient-reported visual analogue score (VAS) improvement of at least 50%. Secondary outcome measures were Urinary Distress Inventory Short Form (UDI-6) score and two-day bladder diary. Patients also provided feedback on adverse effects encountered.
[RESULTS] In the 84 women recruited, initial treatment protocol showed a success rate of 77.2% among those who completed treatment based on VAS, with a statistically significant improvement in mean UDI-6 score of 20.13 (P < 0.01, standard deviation: 12.52). Continued success following tapering protocol of 60.8% and a mean maintenance protocol of 14.2 months was achieved. No adverse effects were reported.
[CONCLUSION] The results from this study are in concordance with previously published literature on the effectiveness and safety of PTNS as a treatment modality for OAB. Further randomised controlled trials to evaluate the optimal treatment protocol are warranted to establish a standardised regime.
[METHODS] This study was a single-arm trial of women requesting third-line treatment for OAB. The primary treatment outcome was patient-reported visual analogue score (VAS) improvement of at least 50%. Secondary outcome measures were Urinary Distress Inventory Short Form (UDI-6) score and two-day bladder diary. Patients also provided feedback on adverse effects encountered.
[RESULTS] In the 84 women recruited, initial treatment protocol showed a success rate of 77.2% among those who completed treatment based on VAS, with a statistically significant improvement in mean UDI-6 score of 20.13 (P < 0.01, standard deviation: 12.52). Continued success following tapering protocol of 60.8% and a mean maintenance protocol of 14.2 months was achieved. No adverse effects were reported.
[CONCLUSION] The results from this study are in concordance with previously published literature on the effectiveness and safety of PTNS as a treatment modality for OAB. Further randomised controlled trials to evaluate the optimal treatment protocol are warranted to establish a standardised regime.
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | bladder
|
scispacy | 1 | ||
| 약물 | third-line
|
scispacy | 1 | ||
| 약물 | OAB
→ Overactive bladder
|
scispacy | 1 | ||
| 약물 | beta-adrenoreceptor
|
scispacy | 1 | ||
| 약물 | Urinary
|
scispacy | 1 | ||
| 질환 | PTNS
→ Percutaneous tibial nerve stimulation
|
scispacy | 1 | ||
| 질환 | Overactive bladder
|
C0878773
Overactive Bladder
|
scispacy | 1 | |
| 질환 | Urinary Distress
|
scispacy | 1 | ||
| 질환 | OAB
→ Overactive bladder
|
scispacy | 1 | ||
| 기타 | tibial nerve
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | muscarinic receptor antagonist
|
scispacy | 1 | ||
| 기타 | sacral
|
scispacy | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
- Mechanisms of Botulinum Toxin Type A Action on Pain.
- Effect of Botulinum Toxin Injection on EMG Activity and Bite Force in Masticatory Muscle Disorder: A Randomized Clinical Trial.
- Botulinum Toxin: An Update on Pharmacology and Newer Products in Development.
- Immunogenicity of botulinum toxin.
- Botulinum Toxin in the Treatment of Headache.